Skip to main content
Banana Farmer logo
Banana Farmer
System Transmission

_

Top Signal
100#1 JOB
Activity
2163Ripe
+917 today
System
Live1m
Terminal Asset View
stockNASDAQ

ACAD

$20.61-3.10%

Acadia Pharmaceuticals Inc

Overripe
Official Site
Market value
24H Total Traded
Total supply
52-Week Range
Ripeness Index
Live Analysis Active

Company Mission

It creates and markets Nuplazid, a prescription drug used to treat hallucinations and delusions in people with Parkinson's disease. Doctors prescribe it to help patients manage these symptoms, improving their quality of life. The company makes money by selling this medication to pharmacies and healthcare systems.

ACA

Industry Context

This company operates in the biotechnology sector, focusing on developing treatments for central nervous system disorders. It competes with larger pharmaceutical firms by targeting niche conditions like Parkinson's disease psychosis. The industry is growing due to aging populations and increased research into neurological health.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified
Asset Diagnostics

Technical Matrix

Scanning
42Matrix
Market Momentum
31.3Oversold / Recovery
Trend Strength
25Active Setup

Momentum Engine

Ready
30
Velocity Score
StaticOptimal FlowMax Vel
Trading Activity
0.8xNormal Volume
Today's Change
-3.10%Live Performance

Social Frequency

Listening
0
Social Freq
0.0x
Normal Vol
X/Twitter Activity
0.0xStreaming
Reddit Buzz
0.0xSynced
System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

© 2026 Precision Engine
0Velocity
Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ACAD across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring
RedditMonitoring
WebMonitoring

Signal Catalysts

Intelligence Narrative Connected

Updated 01:43 PM UTC
As-of As of 2026-03-15T13:27:50.915Z UTC (~15m delay).
Develops treatments for central nervous system disorders, earning revenue from drug sales to healthcare providers and patients.
Monthly chart shows base formation near $20, indicating a strong foundation for potential moves. Watch for price breaking above this level.
Weekly range is narrowing around $22, often a precursor to a significant breakout or breakdown. Monitor if it holds above this support.
Industry trend toward neurological treatments is driving strength, with price holding above $18, signaling positive outlook. Watch for sector momentum.

Educational only.

Precision Intelligence Model
Live Terminal Stream

Loading chart...

Loading chart...

Loading chart...

Loading chart...